GlassScriptPhysician profile
Elmer Murdock
NPI 1700064730
$124,808.72
in general payments reported to CMS, 2019-2025
39 companies · $15K in 2025
The $15K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $9,508 · 2021: $7,168 · 2022: $29K · 2023: $18K · 2024: $22K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $49K · Food and Beverage: $5,216 · Travel and Lodging: $1,864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $48,693.75 |
| Food and Beverage | $5,215.98 |
| Travel and Lodging | $1,863.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $91,435.03 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $24,219.41 | 2019-2025 | Jardiance |
| Teleflex LLC | $1,678.49 | 2025 | Guideliner, Supercross, Trapliner |
| Boston Scientific Corporation | $1,140.34 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Amgen INC. | $1,065.32 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $795.09 | 2019-2025 | |
| Pfizer INC. | $710.07 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $571.49 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $506.79 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $347.47 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| E.R. Squibb & Sons, L.L.C. | $312.09 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $263.25 | 2019-2025 | Cardiomems, Ensite Precision, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $197.08 | 2019-2025 | Farxiga |
| Sanofi-Aventis U.S. LLC | $162.41 | 2019-2023 | |
| Chiesi USA, INC. | $152.74 | 2019-2024 | Kengreal, Cleviprex |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $150.47 | 2019 | |
| Philips North America LLC | $142.29 | 2022 | |
| Acist Medical Systems, INC. | $126.65 | 2023-2024 | |
| Inari Medical, INC. | $91.91 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Imperative Care, INC | $68.26 | 2024 | Symphony Catheter |
| Heartflow, INC. | $68.03 | 2025 | |
| Scpharmaceuticals INC. | $62.07 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $59.45 | 2021-2023 | Fluency Endovascular Stent Graft, Lutonix Drug Coated Balloon |
| Merck Sharp & Dohme LLC | $53.46 | 2021-2024 | Verquvo |
| Elutia, INC. | $45.32 | 2022-2025 | Ecm Patch,Pouch |
| Actelion Pharmaceuticals US, INC. | $44.06 | 2021-2025 | Opsumit |
| Bridgebio Pharma, INC. | $37.56 | 2025 | Attruby |
| Medtronic, INC. | $36.01 | 2021-2023 | Onyx Frontier |
| Surmodics, INC. | $32.91 | 2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Shockwave Medical, INC | $32.54 | 2021-2023 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Kiniksa Pharmaceuticals International, Plc | $31.19 | 2024 | Arcalyst |
| Cvrx, INC. | $28.68 | 2025 | Barostim Neo System |
| Cordis US Corp. | $27.79 | 2025 | Mynx Control Venous |
| Edwards Lifesciences Corporation | $23.06 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kestra Medical Technology Services, INC. | $22.96 | 2023 | Assure Wcd |
| Angiodynamics, INC. | $22.63 | 2025 | Alphavac |
| Veryan Medical Incorporated | $16.69 | 2022 | |
| Abiomed | $15.70 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $11.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elmer Murdock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.